|
summary: This review provides useful guidelines for clinicians using intense immunosuppressive treatments to treat people with very active MS.
authors: Boster A, Edan G, Frohman E, Javed A, Stuve O, Tselis A, Weiner H, Weinstock-Guttman B, Khan O.
source: Lancet Neurol. 2008 Feb;7(2):173-83
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Immunoglobulin
Immunosuppressio
Multiple sclerosis
Sclerosis
|